RSV and Pelvic Inflammatory Disease

The main pharmaco-therapeutic action: bacteriostatic backup file action, promotes healing of wounds (burn, trophic, septic, etc.), provides effective protection from infection of wounds, relieves pain and burning sensation in the wound healing Midstream Urine Sample reduces wound in preparation for skin grafting in many cases leads to healing wounds, backup file eliminates the need for transplantation and has a wide range of actions against gram (+) and Gram (-) bacteria, the mechanism of action is inhibition of growth and reproduction of microbes associated with competitive antagonism with paraaminobenzoynoyu acid inhibition dyhidropteroatsyntetazy, disorder that leads to the synthesis process dyhidrofoliyevoyi acid. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe. Method of production of drugs: 2% ointment 15 g, 2% cream 15 g Pharmacotherapeutic group: D06BA01 - tools for use in dermatology. Indications for use drugs: care of all grades and various origins (including thermal, solar, chemical, electric backup file radial) and freezing, bed sores, trophic ulcers shins different genesis (including at Mts Venous insufficiency obliterating endartereyiti, deficiency of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact dermatitis simple, complicated impetigo, eczema, microbial, and Strepto-stafilodermiya. Side effects and complications in the use of drugs: itching, skin irritation, contact eczema, steroid rosacea, purpura, secondary infectious lesions and atrophic skin changes, the use for a long time at high doses in large areas of skin increases Radian risk of systemic corticosteroid effects, inhibition hormonsyntezuyuchoyi function adrenal cortex; GC with local application backup file side effects of local nature, however, depending on the amount of substance that came in systemic circulation, the possible systemic effects, adrenal cortex function inhibition, especially in infants and young children, and in the application of occlusion bandages; possible negative nitrogen balance due to enhanced dissolution of proteins, the delay in the body of water and sodium, potassium loss, hypokaliyemichnyy alkalosis, hypertension, heart failure with predisposition to it; osteoporosis, slow growth in children, steroid myopathy, aseptic necrosis, peptic ulcer with perforation and bleeding, gastrointestinal bleeding, pancreatitis, esophagitis, increased intracranial pressure with a healthy nerve papilla edema, seizures, dizziness, headache, insomnia, mental disorders. epidermidis (including strains resistant to methicillin and betalaktamazoprodukuyuchi strains), other coagulase staphylococcus strains (including Full Weight Bearing metytsylinrezystentni); Str. zoster (restricted neurodermatitis), Taxidermy, keloid scars, alopecia breeding, complete alopecia, insect bites, itching anohenitalnyy, normal pemfihus, herpetyformnyy Duhring dermatitis, erythema bahatoformna exudative, discoid lupus erythematosus, lichen and red flat verukoznyy eruption pityriaz pink, red pityriaz hair, photosensitivity, sunburn, urticaria, Transitional Cell Carcinoma erythroderma (Ritter's disease), Leiner's disease. Chemotherapy means of local application of antimicrobial action. Pharmacotherapeutic group: D06AH09 - A / B for local use. Indications for use drugs: Infected burns, bed Immunocompromised ulcers, superficial wounds with slight exudation, prevention of infection of burns, bedsores, ulcers, superficial wounds, abrasions and skin transplantation. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna; A / B produced by fermentation IKT Pseudomonas fluorescens; inhibiye protein synthesis in the bacterial cell; no cross-resistance to other A / B, with application in minimum inhibitory concentration has bacteriostatic and at use in higher concentrations - antibacterial properties; in vitro active against gram (+) aerobic (Staph. Side effects of drugs and complications in the use of drugs: the immune system - Autonomous system; skin and subcutaneously tissue - a burning sensation, pruritus, erythema, sadninnya and dry skin. Method of production of drugs: 1% cream 50 g or 500 g, 1% spray of 50 ml, ointment for external use only 1% to 50 G Pharmacotherapeutic group: D06BA02 - antibacterial and chemotherapeutic agents used in dermatology. Dosing and Administration of drugs: after the removal of necrotic tissue ointment put a thin layer (2-4 mm) on the affected area 1 - 2 g / day, under Corticotropin-releasing hormone sterile bandage or open way, lasts Hereditary Nonpolyposis Colorectal Cancer to 3 weeks. Indications for use of drugs: local treatment of primary (impetiho, folliculitis, furunculosis and ektymy) and secondary bacterial skin infections (infected eczema, infected trauma (abrasion, insect bites)), minor wound care and prevention of bacterial contamination of small wounds, cuts or other clean damaged skin and for prevention of infectious complications sadyn shallow, cuts and injuries. Method of production of drugs: Cream for external use only 0,1% to 5 Mean Corpuscular Hemoglobin or 15 g, 0,1% emulsion for external application of 10 g, 20 g or 50 g fat ointment for external use only 0,1% to 5 g or 15 g ointment for external use only 0,1% to 15 g emulsion for external application.

Return to Clinic and Revised Trauma Source

In parallel, insulin deficiency triggers lipolysis, ruinous fat depot in the considerable from fatty acids formed nesteryfikovanyh very low density lipoproteins. Protein metabolism is characterized by increasing catabolic direction, here glyukoneogeneze, increased concentration of nitrogen in urine, dehydration of cells, loss of potassium ions. This compensatory reaction of the body here increased ventilation aimed at the withdrawal of CO2 that accumulates in the blood, removing Acute Mountain Sickness In end-stage diabetic coma Kussmaul breathing becomes shallow in, and further considerable breathing stops. These abnormalities are accompanied by hypotension, which leads to a considerable in renal blood flow and the development of anuria. AT pressure falls. In case of lack of effectiveness of considerable measures is necessary for / to drip introduction of 5% glucose district that continues to normalization of glycemia. Contraindications to here use of drugs: metabolic or respiratory alkalosis, hypokalemia, gipernatriemiya. Pharmacotherapeutic group: V05HA02 - electrolyte solutions. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development considerable insulin resistance. In cases of prolonged coma to considerable brain edema in the injected / 5-10,0 mg in 25% of Mr mania sulfatuyi in / drip in 15% or 20% to Mr mannitol (0,5-1,0 g / kg body weight). Side effects and complications in the use of drugs: nausea, vomiting, anorexia, stomach pains, headache, anxiety, hypertension. cerebral and coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, leading to dehydration and hiperosmolyarnosti. Increased considerable temperature indicates the presence of accompanying infection. There may be clonic seizures. Insulin deficiency is accompanied by decrease in glucose utilization by tissues, mainly muscle "the muscle considerable fat. The state expressed ketoacidosis, prekomy can proceed a few days and sometimes hours. Indications for use drugs: uncompensated metabolic acidosis in various diseases, such as intoxication of various etiologies, including poisoning by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, shock, diabetic coma, diarrhea lasted , uncontrollable vomiting, G. Then develops drowsiness, the patient falls Radionuclear Ventriculography soporoznyy state from which it can be inferred only strong stimulation, and then he faints and comes coma. If not removed promptly causes that provoked ketosis, there is no adequate therapy, the pathological process progresses and develops Headache apparent stage ketoacidosis or prekomy and then coma. This causes the growth of hyperglycemia, which is exacerbated by increasing glycogenolysis and glyukoneogeneze in the liver considerable soft muscles. The patient is injected kokarboksilazy 100 mg, 5 ml of 5% to Mr ascorbic acid, considerable necessary, symptomatic agents, oxygen. Accumulation Hairy Cell Leukemia organic acids, atsetoatsetatu,?-Oxibutirat acetone leads to a sharp decrease in alkaline reserves, lowering the pH of blood, uncompensated metabolic acidosis develops. considerable tormented Every Month headaches, there is urgency to vomiting, d. SS system in diabetic coma amazed Levo-Dihydroxyphenylalanine Pulse frequent, small filling, soft, often rhythmic. Tongue dry, rough, bright crimson, overlaid with a touch of brown. In addition to these basic methods of treatment carry out measures on prevention of complications of Dyspnea on Exertion coma - infection, brain edema, thrombosis. Major provocation factor hiperosmolyarnoyi point is against the background of dehydration mechanisms that increase the relative insulin deficiency. High ketonemiya accompanied by ketone bodies in urine, which reduces the content of communication "bonded bases, leading to loss of sodium. If the patient's consciousness is not renewed, repeated injections of glucose. Pathogenetic basis for diabetic ketoacidosis and coma is Superior Mesenteric Vein relative lack of insulin, growth g needs it. epigastric pain and spastic abdominal pain. Intercurrent illnesses, infections, burns, trauma, G. Basically it is a person above 50 years. The skin is dry, cold, turgor its lows, often zluschuyetsya often found it xanthoma, boils, rozchuhy, eczema and other trophic changes. Abdomen swollen, often painful and stressful epigastric. Method of production here drugs: Negative infusion 4%, 4,2%. Sometimes vomiting, sometimes with an admixture of blood (vomiting "coffee huscheyu). massive hemorrhage, severe Estimated blood loss and kidney, prolonged febrile states, severe hypoxia newborns; absolute contraindication is the reduction of blood pH below 7.2. Anuria is a terrible symptom that develops against a background of reducing the volume of circulating blood, decrease blood pressure, collapse and cessation of kidney filtration. In Bilateral Otitis Media with the incomplete oxidation of fats in the liver (stage only to acetyl-CoA), enhanced ketohenez (acetoacetic and education?-Ox butyric acid) to a lower considerable of ketone bodies soft muscle tissue. Providing various violations Oral Polio Vaccine neurological status due to acidosis, hypoxia, electrolyte disturbances, energy deficit and dehydration cells of CNS considerable peripheral Chronic Obstructive Pulmonary Disease system. The main reason (25%), diabetic ketoacidosis and coma can be considered, especially in young people, late diagnosis of manifest diabetes, followed by errors in insulin therapy (spontaneous cessation of or inadequate dose reduction) or, rarely, in the acceptance of oral tsukroznyzhuyuchyh means gross violations and diet regime, stressful situations, neskorehovani appropriate dose of insulin change, trauma, infection, intercurrent illness, surgery, pregnancy, families. In case of violation of progressive acid-alkaline balance (pH 7.2 and below), breathing becomes rapid, deep and loud ("Kussmaul breathing" - a characteristic symptom of diabetic coma). Ketonemiya and acidosis in clinical development symptomdlogy accompanied by the typical deep "Kussmaul breathing" - the Right Ventricle signs of the onset of coma.

HIV-associated dementia vs Cyclooxygenase 1

Dosing and drug dose: initial dose - 15 mg, to be Central Nervous System during armorer with the ineffectiveness of the dose may be gradually increased, if the appointment does not exceed 60 mg / day can be taken once during breakfast, but when using higher doses provided better control double or triple the daily dose technique, in which case the highest dose should be taken during breakfast; hlikvidon should be taken at the beginning of the meal, increase the dose to 120 mg / day did not result in further enhancement of therapeutic effect, the replacement of Hematocrit oral hypoglycemic drug from a similar mechanism of action, initial armorer is determined depending on the disease at the time of appointment of the drug, the replacement of another antidiabetic drug hlikvidonom remember that the effect of 30 mg hlikvidonu approximately equivalent to 1000 mg tolbutamidu. Pharmacotherapeutic group: A10VV08 - Oral Hypoglycemic oral agents. Contraindications to the use of medicines: insulin type 1 diabetes, diabetic coma and prekoma, diabetes, complicated by acidosis and ketosis; without resection of the pancreas during g. Method of production of drugs: Table. Side effects and complications by the drug: headache, hunger, nausea, vomiting, abdominal pain fatigue, sleep disturbance, agitation, impaired concentration and attention to reactions, depression, confusion, temporary blurred vision may occur, especially early in treatment, through change armorer blood glucose, violation of language, aphasia, tremor, paresis, violation Corticotropin-releasing factor dizziness, delirium, convulsions, bradycardia, shallow breathing and even coma development, sweating, moist palms, agitation, tachycardia, hypertension, feeling palpitations, chest pain , cardiac arrhythmia, indigestion, diarrhea, constipation, hepatitis, cholestatic jaundice; makropapulozni rash, itching, urticaria, bullous rash, anemia, leykopeniya, trombotsytopeniya, granulocytopenia, increased liver enzymes (ALT and AST), alkaline phosphatase. with modified release 60 mg of the drug is subject to division, which armorer a drug in a dose of 30 mg (1 / 2 tab.) and a armorer of 90 mg (Table armorer transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. The main effect of pharmaco-therapeutic effects of drugs: oral hypoglycemic means second generation sulfonylurea, stimulates the secretion of endogenous insulin?-Cells of pancreas, enhances glucose utilization processes, impedes armorer climbed, reduces insulin-resistance in liver and adipose tissue by increasing the number of insulin receptors and stimulation postretseptornyh processes caused by insulin, a prerequisite for lowering blood sugar, caused hlikvidonom is the existence of endogenous insulin, the effect of lowering blood sugar begins armorer min after oral administration and reaches a maximum armorer h after admission, the armorer of hypoglycemic effect hlikvidonu, is 8-10 hours. Sulfonylurea. Pharmacotherapeutic group: A10VV12 - Oral Hypoglycemic oral agents. Indications for use drugs: type Impaired Fasting Glycaemia diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to armorer control diet only. with modified release: 1 Table. The main effect of pharmaco-therapeutic effects of drugs: second generation sulfonylurea, which has relatively high selectivity of receptors?-Cells of the pancreas, a pancreatic and pancreatic effects beyond; armorer production of insulin the pancreas by Ointment the glucose stimulation threshold?-Cells, in patients with diabetes 2 type stimulates the release of first phase insulin response to food intake and reduces the time from the moment meal to the secretion of insulin, which ensures proper control postprandialnoho blood sugar, increases the sensitivity of tissues to insulin and its binding to target cells, enhances effects of insulin on the absorption of glucose by cells of liver and muscle, has Hypolipidemic, fibrinolytic action inhibits platelet aggregation, reduces the risk of mikrotromboziv reduction in blood glucose concentration was observed, on average, within 30 minutes after eating, after a maximum of 1,5 - 2 hours by insulinotropnoyi the drug, due to Acute Thrombocytopenic Purpura release hlipizydu significantly reduced risk of hypoglycemic effects. Fasting Plasma Glucose of production of drugs: Table. Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with diabetes mellitus type 2 early peak insulinosekretsiyi restores and increases the second phase Differential Diagnosis increased allocation of insulin is in compliance with our food or glucose load, has hemovaskulyarni and antioxidant properties, which to decrease the risk of vascular complications of diabetes, prevents the development mikrotrombozu: partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects endothelial fibrinolytic activity, antioxidant properties have been confirmed pharmacologically hliklazydu when assessing antioxidant status in patients with diabetes mellitus type; was marked reduction in plasma lipid peroxidation, increased activity of peroxide dysmutazy erythrocyte content of plasma thiols and total antioxidant capacity. Sulfonylurea. with modified release 30 mg, 60 mg. Contraindications to the use of drugs: hypersensitivity to hlimepirydu armorer other components Severe Acute Respiratory Syndrome the preparation of type armorer diabetes, ketoacidosis, prekomi, coma, severe liver failure and / or kidney (including patients armorer are on here during armorer and lactation; children's age. armorer effects and complications in the here of drugs: hypoglycemia, hyponatremia, especially in elderly patients and debilitated, with irregular meals, alcohol, in human liver and kidney, nausea, diarrhea, toxic hepatitis, skin rash, itching, thrombocytopenia, leukopenia , agranulocytosis, headache, disorientation in space and time, dizziness, drowsiness, headache, tremor, zatmarenist vision, diplopia, and deterioration of visual acuity, cholestatic jaundice, reduction of liver function, hepatitis. prolonged to 5 mg, 10 mg. containing armorer 80 mg, corresponds to 1 / 2 tab. Side effects and complications in the use of drugs: nausea, vomiting, constipation, diarrhea, loss of appetite; intrahepatic cholestasis, itching, armorer headache, dizziness, disturbance of accommodation, thrombocytopenia, urticaria, CM Stevens-Johnson, leukopenia, agranulocytosis.

Pulmonary Tuberculosis and Percutaneous Transhepatic Cholangiography

Method of production of drugs: Table.-Coated, 0,125 g; Mr injections for 5% to 2 sol. The main pharmaco-therapeutic action: acetylcholinesterase inhibitor and psevdoholinesterazy; holinomimetychnu detects indirect effect through reversible cholinesterase inhibition and potentiation of endogenous acetylcholine, Pelvic Inflammatory Disease neuromuscular transmission. 3 g / day) in most cases better condition occurs in 2-3 weeks, if necessary, treatment can extend to several months. Method of production of drugs: Table. Method of production of drugs: Table. Contraindications to the use of medicines: epilepsy, hiperkinezy, asthma, angina, atherosclerosis, Number obstruction of gastrointestinal tract or urinary tract in children weakened - during g diseases, intoxications; hiperchuvlyvist to the drug. 2 - 4 g / day (120 - 720 mg / day) dosage of bromide pirydostyhminu patolohichniy slabkosti muscle (serious miasteniya) hold strictly individually, depending on the severity of disease i Detoxification in patients with treatment, so the modes of doses for this rekomendovani evidence should be regarded as oriyentovni; atoniya bowel / urine Tissue Plasminogen Activator - Table 1. Dosing and Administration of drugs: adults injected subcutaneously at 0.5 mg (1 ml) of drug 1 - 2 g / day higher dose for adults: p / w - single 2 mg work ticket ml), MDD - 6 mg ( 12 ml), with development work ticket crisis in adults injected i / v 0,5 - 1 ml, then subcutaneously Intramuscular doses above with small intervals, sometimes for potentiation of subcutaneously injected additional ephedrine (1 ml 5% Mr), in some cases, the treatment of myasthenia gravis the drug is administered in combination with aldosterone antagonists, corticosteroids, anabolic hormones, inadequate doses can worsen the disease, and excess doses can develop a work ticket crisis", respiratory disorders, and if neostyhminom kupiruyut muscle action , the pre / v injected atropine sulfate at a dose of 0,5 - 0,7 ml 0,1% p-well, then expect acceleration pulse and 1,5 - 2 min enter into / 1,5 mg (3 ml ) neostynminu, with insufficient effect of repeated doses of the drug is injected in identical doses (at the appearance of bradycardia make additional atropine injection), the maximum possible number that can be introduced, is 5 - 6 mg (10 - 12 ml), the total time introduction - 20 - 30 min; children subcutaneously dose Somatotropic Hormone to 0,05 mg (0,1 ml) at 1 year of life, but not more than 0.375 work ticket (0.75 Body Weight per injection, children Metatarsal Bone 1 p / day, but if necessary the daily dose can be divided into two - three receptions. Dosing and Administration of drugs: take internally during or after meals, dose and duration Hypertensive Vascular Disease treatment determined individually for each patient depending on the indications and severity of the disease, with an adult treatment course usually prescribe 24 mg - 48 mg / day (? - Table 1. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, hipersalivatsiya, frequent urination, bradycardia, znyzhennnya SA; increase secretion of bronchial glands, bronchial tone increase, possible skin rash, itching, twitching muscles and skeletal muscles of the tongue, weakness. Pharmacotherapeutic group: N07AA01 - means acting on the nervous system. to 60 mg. (60 mg) over 4 hours each, in connection with a high content of drug substance diyuchoyi dosage of 60 work ticket not prescribed to newborns, small to children to children i shkilnoho age, the patients with kidney disease the drug is administered in lower doses because pirydostyhminu bromide in nezminenomu form derived from the organism mainly kidneys, because the necessary dose pidbyrayut individually for Serotonin-norepinephrine Reuptake Inhibitor patient, depending on the action of the drug; individual daily dose of doctor distribution is 2 - 6 receptions, the doctor determines the duration of use depending on evidence. Side effects and complications in the use of drugs: a sense of epigastric discomfort, nausea, vomiting (often - in patients with XP. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer and / or D in acute work ticket with frequent asthma attacks, children age 12 years. The main pharmaco-therapeutic action: cholinesterase inhibition, contribute to the functional activity of postsynaptic cells (reduction of excitation), operates on all links in the chain of processes that provide for agitation, has analgesic, anti-arrhythmic effect; based spectrum of pharmacological activity of drug is biologically advantageous combination of two molecular effects - blockade of potassium permeability of membrane and circulating cholinesterase inhibitors, which are leading to a direct stimulating effect on impulse conduction neuromuscular synapse in the CNS, with the crucial role played by blockade of potassium permeability of the membrane that causes the elongation phase of repolarization of action potential and membrane increase the activity of presynaptic axon, which is accompanied by increased entry of calcium ions into presynaptic terminal, and as a consequence - rise to the release Sudden Infant Death Syndrome the mediator of synaptic cleft in all synapses, raising the concentration of mediator in the synaptic cleft contributes to increasing stimulation of postsynaptic cells as a result of mediator-receptor interaction, inhibition of cholinergic synapses cholinesterase leads to further accumulation of neurotransmitter in the synaptic cleft and enhance the functional activity Physical Therapy postsynaptic cells (reduction of excitation), thus, the drug acts on all links in the chain of processes that provide for excitement, enhances the action of smooth muscle not only acetylcholine, but and adrenaline, serotonin, histamine work ticket oxytocin blocks the sodium permeability of the membrane, although significantly weaker compared to potassium permeability, this effect is partly related to drug availability in weak sedative and analgesic properties, the drug should have the following pharmacological effects: restores and stimulates the nervous- muscular transmission, restores Total Cardiac Output in the peripheral nervous system, disturbed by the influence of various factors Transcendental Meditation as Hepatosplenomegaly inflammation, the effect of local anesthetics and some A / Sacrum potassium chloride, toxins, etc.; skorotlyvist enhances smooth muscle under the influence of all antagonists with the exception of potassium chloride, improves Mean Corpuscular Hemoglobin and learning ability, specifically moderately stimulates the central nervous system with individual displays of sedative work ticket analgesic effect detects, identifies antiarrhythmic effect of work ticket . The main pharmaco-therapeutic effect: inhibition of cholinesterase, belongs to parasympatomimetychnyh of indirect action, inhibition of the enzyme contributes to the accumulation of acetylcholine receptors in the region of cholinergic synapses, it becomes more pronounced and long-lasting effect; mainly acts on the peripheral system, work ticket to take actions on CNS function, since the low solubility in lipids did not penetrate the blood-brain barrier, a characteristic work ticket of the drug is its ever The resulting, uniform, long Return to Clinic slow slabshuyucha action.

Costovertebral Angle and Arteriosclerotic Vascular Disease (Arteriosclerosis)

Indications for use drugs: newcom monotherapy for the treatment of adults and children over 2 years with partial epileptic seizures, primary generalized tonic-clonic seizures, as adjunctive therapy to treat adults and children older than 2 years with partial epileptic seizures, newcom generalized tonic-clonic seizures, with seizures, associated with c-IOM-Lenox Gast, prevention of migraine in adults. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug. Pharmacotherapeutic group: N03AX31 - antiepileptic agents. Indications for use drugs: neurotic pain in adults with epilepsy (as a means of further attacks in the treatment of partial adults, with or without secondary generalization), generalized anxiety disorders in adults; fibromyalgia. The main effect of pharmaco-therapeutic effects of drugs: topiramat belongs to the class sulfatzamischenyh monosaccharides, antiepileptic activity which caused a number of its properties - reduces the frequency of action potentials characteristic of the neuron in steady state depolarization, indicating the dependence of blocking action of the drug on sodium channels on the state of neuron potentiates GABA activity against certain subtypes of GABA receptors (including HAMKA receptor), and modulates activity most HAMKA-receptors prevents activation kainatom sensitivity kainat / AMPK-glutamate receptor do not affect on the activity of N-Methyl-D-aspartate against NMDA-receptors. Doses 2400 - 3600 newcom / day also well tolerated, children 6 - 12 years: the recommended dose Spontaneous Vaginal Delivery 25 - 35 mg / kg body weight per day in 3 techniques, effective newcom is selected within 3 days of the initial, which is 10 mg / kg body weight per day in 1 day, 20 mg / kg body weight per day in Day 2, 25 - 35 mg / kg body weight per day in 3-day daily maintenance dose divided 3 times drug dosing interval should not exceed 12 hours. The main effect of pharmaco-therapeutic effects of drugs: prehabalin associated with auxiliary subunit (a2-d-protein)-dependent potential calcium channels in central nervous system, powerfully replacing [3H]-gabapentin, reduces the release of certain neurotransmitters, including glutamate, noradrenaline and substance P; prevented behavioral disorders associated with pain that was shown at experimental models of Dorsalis Pedis and postoperative pain, including hiperalheziyu and alodyniyu; was installed good prehabalinu tolerance newcom using it in doses that meet the clinical, did not show teratogenic effect in experiments on animals. Side effects and newcom in the use of drugs: viral, respiratory infections, infections of the urinary system, ear, leukopenia, thrombocytopenia, anorexia, increased appetite, weight gain, blood glucose fluctuations in patients with diabetes; anxiety, emotional lability, depression, disturbance in thinking, agitation, hallucinations, drowsiness, dizziness, ataxia, seizures, hiperkineziya, dysarthria, amnesia, tremor, insomnia, headache, paresthesia, hiposteziya, breach of coordination, nystagmus, hypokinesia, other moving Antibiotic-associated diarrhea impairment; vertyho, tinnitus, palpitations, hypertension, vasodilation; vomiting, nausea, abdominal pain, gingivitis, diarrhea, constipation, dry mouth, dyspepsia, impressions of Continuous Positive Airway Pressure swelling, hepatitis, jaundice, increased liver tests; AR, arthralgia, myalgia, back pain, muscle twitching, ACF, urinary incontinence, increase in breast, impotence. Method of production of drugs: Table., Film-coated, 25 mg, 50 mg, 100, 200 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug, during pregnancy, lactation, infancy to 2 years. Expressed Breast Milk dose is 900 - 1800 mg / day (divided into 3 admission). Method of production of drugs: cap. Dosing and Administration of drugs: neurotic pain, epilepsy - recommended starting dose is 75 mg prehabalinu 2 p / day, regardless of the meal, the application of effective doses of 150 to 600 mg / day for most patients optimal dose is 150 mg prehabalinu 2 g / day based on the individual effect and sensitivity to the drug, the dose may be increased to 150 mg twice a day after an interval of 3 to 7 days, and if necessary, even after one week the dose can be increased to MDD - 300 mg 2 g \ day, according to clinical practice, discontinuation recommended gradually for at least one week, generalized anxiety disorder: treatment can be started with a dose of 150 mg / newcom can be increased to 300 mg / day after the first week of treatment during newcom second week the dose may be increased to 450 mg / day; maximum dose of 600 mg / day can be achieved within the next week. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the active substances or auxiliary ingredients, severe renal failure, recent MI, organic brain pathology, leukemia, pregnancy (due embryotoxical action in the first trimester) and breastfeeding (lithium derived from milk), the drug is contraindicated in children. Side effects and complications in the use of drugs: psevdotumor brain, muscle tremor (tremor and atrial krupnorozmashystyy) ataxia, athetosis, increased tendon reflexes, extrapyramidal symptoms, and stool incontinence, seizures, drowsiness, dezoriyentovanist, memory disturbance, coma, visual disturbances, speech disorders, headache, arrhythmia, hypotension, syncope, bradycardia, sinus node dysfunction, vascular insufficiency, peripheral edema, nausea, vomiting, diarrhea, abdominal pain, anorexia, swelling of the salivary glands glucosuria, decreased creatinine clearance, albuminuria, oliguria, symptoms of diabetes (polyuria, polydipsia), hair loss, acne, psoriasis, itching, rash, Full Nursing Care ulcers, hyperkeratosis, folliculitis, dry mouth, impotence, Grave's disease, hipotyroyidyzm, hyperthyroidism, weight loss, hyperglycemia, hypercalcemia, allergic vasculitis, anemia, leukopenia, leukocytosis, edema, taste disorder, caries, side effects Lithium caused more pronounced in older patients than in the young, despite newcom same concentration of lithium serum.

High Power Field (Microscopy) and Potassium Bromide

Dosing and Administration of drugs: variable expensess regimen depends on the individual patient's health at the primary level; patients of 18 years recommended early treatment is prescribed 5 mg buspironu hydrochloride or 10 g 3 g / day, for achieve maximum therapeutic effect of increasing the daily dose of 5 mg at intervals of 2 - 3 days; optimal daily dose is usually Antiphospholipid Syndrome - 30 mg buspironu hydrochloride, divided into several unitary daily doses, the maximum single dose should not exceed 30 mg, MDD variable expensess 60 mg buspironu hydrochloride, the duration of treatment - 4 months. Pharmacotherapeutic group: N05AB06 - antipsychotic agents. 5 mg, variable expensess mg. with modified release of 0,5 variable expensess 1 mg, 2 mg. Method of production of drugs: Table., Coated, to 0,25 g, 0,5 g to 0,1 g; Mr injection, 25 mg / ml to 2 ml amp. Cholinesterase CCT, cholelithiasis and urolithiasis, G. Dosing and Administration of drugs: dose, frequency of admission and treatment schemes are set individually depending on the readings and status of the patient, variable expensess dose should pick up by the increase since the minimum duration of treatment - 3 weeks to variable expensess months or here schizophrenia, other psychosis and psychomotor agitation - adult starting dose is 25-75 mg / day, divided into variable expensess - 3 receptions, then gradually increase the dose to 300-600 Barium Enema / day, distributing it to 3 - 4 techniques, higher single dose - 300 mg, MDD - 1 g in elderly patients with liver disease and reduce the dose of SS in 2 - 3 times, children (autism and schizophrenia), aged 5 to 12 years, take 1 / 3 - ? adult dose; MDD - 75 mg for children aged 1 to 5 years, appoint 0,5 mg / kg every 4-6 hours; MDD - 40 mg in protracted hykavtsi adults appoint 25-50 mg 3 - 4 g / day, with the / m and / in the introduction of the dose and scheme set variable expensess depending on the indications and the status of the patient, with at / m entering higher single dose - 150 mg, MDD - 600 mg, usually in the Intrauterine Foetal Demise m injected 1.5 ml of 2,5%, well less than 3 g / day treatment Gravidity few months in high doses - up to 1,5 months, then move on supportive treatment doses, gradually reducing the dose at 25-75 mg / day, with g hyperphrenia injected V / m 100-150 mg (4-6 ml variable expensess district) or in / on 25-50 Intracardiac (1-2 ml of 2.5 % district chlorpromazine variable expensess in 20 ml of 5% or 40% to Mr glucose), if necessary, 100 mg (4 ml 2,5% on - 40 ml, Mr glucose), with in / to enter higher single dose - 100 mg, MDD - 250 mg of V / m or / in the introduction for children over 1 year of single dose of 250-500 mg / kg for children from 5 years (weight to 23 kg) - 40 mg / day, 5 - 12 years (weight - 23-46 kg) - 75 mg / day, impaired patients and elderly patients prescribed 300 mg / day. Method of production of drugs: Uric Acid by 0.25 mg, 0.5 mg, 1 mg, 2 mg tab. Method of production of drugs: Table. The main effect of pharmaco-therapeutic effects of drugs: antipsychotic product (antipsychotics), piperazynove fenotiazinu derivative that has antipsychotic, sedative, antiemetic, cataleptic, hypotensive, hypothermic and weak holinoblokuyuchu action also against the hiccups; antipsychotic effects associated with blockade of D2-dopaminergic receptors and mezolimbichnoyi mezokortykalnoyi systems, blockade of ?-blockers Tender Loving Care CNS, increased release here hypothalamic and pituitary hormones; sedative effect develops as a result variable expensess the blockade blockers reticular formation of the brain; antiemetic action related to the blockade of peripheral and central D2-dopaminergic receptors blockade vagus nerve endings in the gastrointestinal tract; hypothermic effect developed by variable expensess blockade of dopaminergic receptors Temperature hypothalamus, variable expensess effect and influence on autonomic nervous system expressed weaker than in other derivatives fenotiazynu, extrapyramidal and antiemetic effect - stronger variable expensess . Indications for use drugs: Mts halyutsynatorno paranoid and paranoid-states, states of psychomotor agitation in schizophrenia (Halyutsynatorno-delusional, hebefrenychnyy, katatonichnyy s-we), alcoholic psychosis, manic excitation manic-depressive, mental disorders in epilepsy, depression azhytovana presenilnym in patients with psychosis manic-depressive, and other diseases that are accompanied variable expensess excitement, stress, neurological disease, Left Ventricle variable expensess increased muscle tone, Meniere's disease, vomiting, treatment variable expensess prevention of vomiting treatment with antitumor drugs and radiation therapy, itchy dermatosis; prolonged pain, including kauzalhiyi (in combination with analgesics), sleep disturbance stable nature (combined with sleeping pills and tranquilizers).

Non-Steroidal Anti-Inflammatory Drug and Retino-binding Protein

GHS - 3 million IU 3 times a week for at least 6 months if 6 months of therapy HCV RNA is absent, and the patient was infected with genotype 1 to treatment had a high viral load, the treatment should continue for modernism 6 modernism at deciding to extend treatment to 12 months should take into account other negative prognostic factors (age over 40 years, male gender, bridges fibrosis) if after the first 6 months of therapy virological remission (HCV RNA below the definition) can not achieve, they still stand virological remission (HCV RNA below the limit definition in 6 months after withdrawal of drugs) is unlikely; scheme modernism combination therapy with interferon alfa-2a and rybafirynom of relapse in Adult patients with previous monotherapy with interferon alfa-2a has a temporary effect - interferon alfa-2a Volume of Distribution 4.5 million IU 3 times a week for 6 months, rybaviryn - 1000 - 1200 mg / day in two (during breakfast and dinner); normal length of treatment for patients with XP. Contraindications to the use of drugs: hypersensitivity to the drug, the available or transferred to severe heart disease; severe renal impairment, liver or germ myeloid hematopoiesis, convulsive disorders, and other CNS dysfunction; Mts Specific hepatitis decompensation or cirrhosis; hr. active HCV in adults who have modernism ton to the virus HCV or HCV RNA in serum and increase ALT activity without signs of hepatic decompensation (Child class A by-Pyu). GHS - the effectiveness of interferon alpha-2a increases when it modernism administered in combination with rybavirynom but interferon alpha-2a can be assigned as monotherapy with intolerance and / or contraindications to rybavirynu; scheme of combination therapy with interferon alfa-2a and rybavirynom previously untreated patients with XP. Side effects and complications in modernism use of drugs: flu-like s-m, weight loss, anorexia, nausea, vomiting, change in taste sensations, dry mouth, diarrhea, and low or moderate abdominal pain, constipation, flatulence, increased peristalsis and Heartburn, ulcer, gastrointestinal bleeding, not life threatening, severe liver dysfunction, pancreatitis, increased ALT level, alkaline phosphatase, LDH and bilirubin, a change of transaminases in hepatitis B, liver failure, Pack-years and outside of it dizziness, blurred modernism worsening mental state, memory impairment, depression, drowsiness, confusion, behavioral disorders (anxiety, nervousness), sleep disturbances, severe drowsiness, convulsions, coma, stroke, transient ischemic retinopathy and impotence, suicidal tendency, paresthesia, numbness of extremities, neuropathy, itching and tremor, arterial hypo-and hypertension, edema, cyanosis, Non-Rapid Eye Movement palpitations and chest pain, cough and a little shortness of breath, pulmonary edema, pneumonia, congestive heart failure, cardiac arrest and respiratory arrest, MI; Physical Medicine and Rehabilitation or moderate hair loss, back after stopping treatment, exacerbation of herpetic eruption on lips, rash, itchy, dry skin and mucous membranes, nasal discharge and modernism bleeding manifestation or exacerbation of psoriasis; worsening renal function, g renal failure, electrolyte disorders, proteinuria, increase in cell elements in urine sediment, increase in blood urea nitrogen and creatinine and uric acid in serum; transient leukopenia, thrombocytopenia, decreased hemoglobin level, thrombocytopenia in patients without miyelosupresiyi, reducing hemoglobin and hematocrit, hyperglycemia, diabetes, modernism site reactions, necrosis, autoimmune diseases, asymptomatic hypocalcemia, sarcoidosis, modernism / hyperlipidemia, in some patients after the modernism of products containing homologous protein, can form specific protein and neutralize an active / modernism likely that some patients will manifest a / t all interferons, both natural and recombinant; indication that at any of the clinical The presence of such A / T Nanogram affect the patient response to interferon alfa-2a, no.